3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
2
Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pseudomyxoma Peritonei
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Melanoma
1
Lymphoma, B-Cell
1
Lymphoma
1
Kidney Transplantation
1
Digestive System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Adenocarcinoma, Clear Cell
1
Interventions
Cytarabine
3
Injections
2
Idarubicin
2
Gemtuzumab
2
Filgrastim
2
Decitabine
2
veliparib
1
fludarabine phosphate
1
aldesleukin
1
Whole-Body Irradiation
1
Temozolomide
1
Peripheral Blood Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Daunorubicin
1
CPX-351
1
Busulfan
1
Bone Marrow Transplantation
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Acute
×
Alemtuzumab
×
1 year
×
Clear all
No trials found.